Aspira Women's Health Inc. (AWH) EV/EBITDA Multiple
Aspira Women's Health is developing a system for the early detection of gynecological pathologies through a strategic alliance with clinics. The EV/EBITDA market dynamics, currently valued at , reflect the impact of fierce competition with industry behemoths, forcing the business to create unique tests. Meanwhile, liquidity shortages and the potential refusal of insurers to reimburse diagnostic costs hinder stability.
Analytical breakdowns for Aspira Women's Health
- market price and analyst price targets:
- market capitalization details:
- issuer book value statistics:
- company liabilities and liquidity data:
Debt to Equity Aspira Women's Health|AWH - Ratio of Long-Term Indebtedness to Capital|Short-Term Debt to Equity Aspira Women's Health Inc.|AWH - Company Aggregate Indebtedness|Debts to Book Capitalization Aspira Women's Health Inc|AWH - Long-Term Debt Volume|Company Short-Term Debt Aspira Women's Health|Quick Ratio aspirawh.com
- business earnings and investment ratios data:
AWH - Net Profit|Future Profit Aspira Women's Health|AWH - Company Value to Net Income|Projected Price to Earnings Aspira Women's Health|AWH - Price/Earnings to Growth Multiple|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Aspira Women's Health Inc|AWH - Profit before interest, taxes and amortization|Earnings per share for the last twelve months Aspira Women's Health|AWH - Net earnings per share for the last 12 months|Quarterly EPS earnings growth aspirawh.com|AWH - Earnings per share growth rate in current year|Net earnings per share growth forecast for next year Aspira Women's Health
- sales volume and revenue indicators:
Fundamental valuation:Vermillion AWH
The EV/EBITDA multiple compares the total enterprise value, including debt, with operating profit before taxes and depreciation, determining the payback period of assets. By analyzing the EV/EBITDA trend over time on the GURU.Markets platform, an investor assesses cash flow generation efficiency relative to market value. For Aspira Women's Health (AWH), this metric reflects the value of a diagnostic testing infrastructure that scales through laboratory partnerships without the need for capital-intensive mergers.
Analysis of competing companies
Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Agilent Tech A|Total Company Value to Operating Income Before Depreciation Ratio Quest Corp (DGX)|Illumina, Inc. - EV/EBITDA Multiple|Total Company Value to Operating Income Before Depreciation Ratio exactsciences.com EXAS|Revvity (RVTY) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|BIO - Total Company Value to Operating Income Before Depreciation Ratio|NNNN (Anbio Tech) - EV/EBITDA Multiple|EV/EBITDA Multiple Nordion|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization QuidelOrtho (QDEL)|Total Company Value to Operating Income Before Depreciation Ratio opko.com|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization CareDx Inc CDNA|MRVI (Maravai LifeSciences Holdings) - Company Value to Operating Income Before Depreciation Ratio|Fulgent Corp - EV/EBITDA Multiple|Total Company Value to Operating Income Before Depreciation Ratio Standard BioTools Corp LAB|Cytek Biosciences, Inc. (CTKB) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|orasure.com - Business Value to Operating Income Before Depreciation|XGN (Exagen Inc) - EV/EBITDA Multiple|EV/EBITDA Multiple MDxHealth S.A.|Enterprise Value to EBITDA Ratio LUCD (Lucid Diagnostics Inc)|PRE (prenetics.com) - Business Value to Operating Income Before Depreciation|Insight Molecular Diagnostics Inc - Enterprise Value to EBITDA Ratio|TRIB - Enterprise Value to EBITDA Ratio|PRPH - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Company Value to EBITDA Ainos Inc|Co-Diagnostics Corp (CODX) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Enterprise Value to EBITDA Ratio Heart Test Labs|BMRA (Biomerica, Inc.) - EV/EBITDA Multiple|Company Value to EBITDA Cardio Diagnostics Holdings, Inc. CDIO|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Onconetix (ONCO)|Virax Biolabs Group Limited - Enterprise Value to Operating Income Before Depreciation|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Bluejay BJDX|Total Company Value to Operating Income Before Depreciation Ratio Accelerate Diagnostics Inc (AXDX)|CNTG: Enterprise Value to EBITDA Ratio|Business Value to Operating Income Before Depreciation ENZ (Enzo Biochem, Inc.)|FRES: EV/EBITDA Multiple|Genetic Technologies Limited - Business Value to Operating Income Before Depreciation|ME (23andMe Inc.) - EV/EBITDA Multiple|Company Value to EBITDA Psychemedics Inc PMD
